Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of DMARDs in the treatment of Sjögren’s syndrome.

Disease-modifying anti-rheumatic drugs (DMARDs) for Sjogren’s syndrome / R. Gualtierotti, M. Rota, M.A. Lopez-Olivo, F. Spadari, C. La Vecchia, M. Cugno. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - 2021:5(2021 May 10), pp. CD014529.1-CD014529.11. [10.1002/14651858.CD014529]

Disease-modifying anti-rheumatic drugs (DMARDs) for Sjogren’s syndrome

R. Gualtierotti
Primo
;
F. Spadari;C. La Vecchia
Penultimo
;
M. Cugno
Ultimo
2021

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of DMARDs in the treatment of Sjögren’s syndrome.
Settore MED/09 - Medicina Interna
Settore MED/16 - Reumatologia
10-mag-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gualtierotti_et_al-2021-Cochrane_Database_of_Systematic_Reviews.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 173.24 kB
Formato Adobe PDF
173.24 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/859125
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact